Results 41 to 50 of about 13,441 (261)

Ayahuasca drinking using a two-bottle choice procedure in male mice

open access: yesScientific Reports
Ayahuasca has been proposed as a treatment for substance use disorders. However, because of its hallucinogenic properties, studies investigating its abuse potential are needed.
Natali D. Kisaki   +12 more
doaj   +1 more source

Registered Clinical Trials of Ayahuasca and DMT: A Scoping Review

open access: yesClinical Pharmacology &Therapeutics, EarlyView.
Interest in ayahuasca and its main component, N,N‐Dimethyltryptamine (DMT), has currently moved from historical and experimental use into modern clinical development. Yet, current evidence is fragmented, and systematic mapping of trial methods and design choices remains limited.
Tijana Stojanović   +4 more
wiley   +1 more source

Psychedelics and Immunomodulation: novel Approaches and Therapeutic Opportunities [PDF]

open access: yes, 2017
Classical psychedelics are psychoactive substances, which, besides their psychopharmacological activity, have also been shown to exert significant modulatory effects on immune responses by altering signaling pathways involved in inflammation, cellular ...
Szabó, Attila
core   +4 more sources

A quantitative textual analysis of the subjective effects of ayahuasca in naïve users with and without depression

open access: yesScientific Reports, 2023
Ayahuasca is a brew with psychoactive properties that has been used as an entheogen for centuries, with more recent studies suggesting it is a promising treatment for some clinical disorders.
Lucas Cruz   +5 more
doaj   +1 more source

Changes in mental health, wellbeing and personality following ayahuasca consumption: Results of a naturalistic longitudinal study

open access: yesFrontiers in Pharmacology, 2022
Background: Naturalistic and placebo-controlled studies suggest ayahuasca, a potent psychedelic beverage originating from Indigenous Amazonian tradition, may improve mental health, alter personality structure, and reduce alcohol and drug intake.
Daniel Perkins   +9 more
doaj   +1 more source

Cannabis Indica as a Motivation for Foreign Travel by Polish Citizens [PDF]

open access: yes, 2016
Based on an anonymous on-line questionnaire survey, conducted among 1000 respondents, the authors present their demographic, socio-economic and spatial profile, their attitude to cannabis and the tourist trips they went on (scale, directions ...
Matczak, Andrzej   +1 more
core   +1 more source

Recreational Drug Use at a Music Festival: A Dual Approach Using Hair Biomarkers Analysis and Participant Self‐Reported Drug Use

open access: yesDrug Testing and Analysis, EarlyView.
Combined self‐report and hair analysis in festival attendees (n = 249) revealed substantial discrepancies in drug use reporting, particularly for stimulants and dissociatives. This integrated approach enhances detection of poly‐drug use and provides a more reliable basis for monitoring and harm‐reduction strategies.
A. Y. Simão   +4 more
wiley   +1 more source

Psychedelic‐assisted treatment for substance use disorder: A narrative systematic review

open access: yesAddiction, EarlyView.
Abstract Background and aims This is the first systematic review of the extant literature on all major psychedelic‐assisted treatment for alcohol use disorder (AUD), tobacco use disorder (TUD) and other substance use disorders (SUD). We aimed to summarise the evidence for efficacy of psychedelic‐assisted treatment for AUD, TUD, and SUD; to evaluate its
Theodore Piper   +7 more
wiley   +1 more source

An ontogenic study of the behavioral effects of chronic intermittent exposure to ayahuasca in mice

open access: yesBrazilian Journal of Medical and Biological Research
Ayahuasca is a beverage obtained from decoctions of the Banisteriopsis caapi plus Psychotria viridis. In religious contexts, ayahuasca is used by different age groups.
N.F. Correa-Netto   +8 more
doaj   +1 more source

Effects of Long-Term Ayahuasca Administration on Memory and Anxiety in Rats. [PDF]

open access: yesPLoS ONE, 2015
Ayahuasca is a hallucinogenic beverage that combines the action of the 5-HT2A/2C agonist N,N-dimethyltryptamine (DMT) from Psychotria viridis with the monoamine oxidase inhibitors (MAOIs) induced by beta-carbonyls from Banisteriopsis caapi.
Vanessa Manchim Favaro   +3 more
doaj   +1 more source

Home - About - Disclaimer - Privacy